I would guess that the 300% references the royalty increases,
17/18 was $889,302 and 16/17 was 167,134 which is greater that 300% yoy.
Perhaps the 1.6M was an adjusted fugure based on the 1.5M mentioned in the annual report. (There was a brief comment at the agm of a discrepancy in the figures P&G versus what OBJ understood to have been manufactured.)
Even better would be if there are 1.6M devices out there in the market as we speak awaiting invoicing!
- Forums
- ASX - By Stock
- WFL
- CES 2019
CES 2019, page-133
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online